The primary objectives of Core B are to supportdevelopment of study design, management of data collection, and performance of statistical analyses to validly test the research hypotheses and questions under investigation in the Biology of the Prostate Cancer Prevention Trial (PCPT) Program Project. Core B will play a pivotal role in the Program Project, interacting with every Project and Core. In the study-design phase, Core B will assist investigators in formulating studies that can feasibly address the questions of scientific interest, are amenable to analysis by statistical and data-mining methods, and will ultimately yield statistically valid and interpretable results. An equally important role for Core B will be database design and coordination of the selection, shipping, and accumulation of results from analyses on serum, white blood cell and tissue samples. This Core will be responsible for managing the overall data infrastructure for all Projects and Cores involved in this program project. This includes maintaining the clinical database, electronic transfer of lab data over secure pathways, tracking samples and verifying that the necessary material is sent to the correct laboratory at the correct time, and ensuring the security and confidentiality of alldata. This core will also provide uniform high-quality support for all statistical analyses, using both standard and specialized biostatistical methods. The overall goal of this program project is to identify factors that are associated with prostate cancer and high grade prostate cancer, and to identify factors that may predict who may and may not respond to finasteride treatment for the prevention of prostate cancer. The revised Project addresses all reviewer concerns, including those for justifying expected effect sizes and clarifying our approach to multiple testing of polymorphisms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA108964-02
Application #
7311254
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
2
Fiscal Year
2006
Total Cost
$285,954
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Tang, Li; Platek, Mary E; Yao, Song et al. (2018) Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 39:125-133
Winchester, Danyelle A; Till, Cathee; Goodman, Phyllis J et al. (2017) Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. Prostate 77:908-919
Miles, Fayth L; Goodman, Phyllis J; Tangen, Catherine et al. (2017) Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial. Nutrients 9:
Chen, Haitao; Liu, Xu; Brendler, Charles B et al. (2016) Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial. Prostate 76:1120-9
Murtola, Teemu J; Gurel, Bora; Umbehr, Martin et al. (2016) Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 25:463-9
Price, Douglas K; Chau, Cindy H; Till, Cathee et al. (2016) Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 122:2332-40
(2016) Correction: Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial. Cancer Prev Res (Phila) 9:116-7
Patel, Darshan P; Schenk, Jeannette M; Darke, Amy et al. (2016) Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU Int 117:500-6
Travis, Ruth C; Appleby, Paul N; Martin, Richard M et al. (2016) A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res 76:2288-2300
Winchester, Danyelle A; Gurel, Bora; Till, Cathee et al. (2016) Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial. Prostate 76:565-74

Showing the most recent 10 out of 71 publications